| dc.contributor.author | Adamopoulou, Eleni |  | 
| dc.contributor.author | Naumann, Ulrike |  | 
| dc.date.accessioned | 2017-04-07T08:27:50Z |  | 
| dc.date.available | 2017-04-07T08:27:50Z |  | 
| dc.date.issued | 2013 |  | 
| dc.identifier.issn | 2162-402X |  | 
| dc.identifier.uri | http://hdl.handle.net/10900/75741 |  | 
| dc.language.iso | en | de_DE | 
| dc.publisher | Austin, Tex. : Landes Bioscience | de_DE | 
| dc.relation.uri | http://dx.doi.org/10.4161/onci.25219 | de_DE | 
| dc.rights | info:eu-repo/semantics/closedAccess |  | 
| dc.subject.ddc | 570 | de_DE | 
| dc.subject.ddc | 610 | de_DE | 
| dc.title | HDAC inhibitors and their potential applications to glioblastoma therapy | de_DE | 
| dc.type | Article | de_DE | 
| utue.publikation.seiten | ;e25219 | de_DE | 
| utue.personen.roh | Adamopoulou, Eleni |  | 
| utue.personen.roh | Naumann, Ulrike |  | 
| dcterms.isPartOf.ZSTitelID | Oncoimmunology | de_DE | 
| dcterms.isPartOf.ZS-Issue | 1 | de_DE | 
| dcterms.isPartOf.ZS-Volume | 125 | de_DE | 
| utue.fakultaet | 04 Medizinische Fakultät | de_DE |